An interventional study of Acupressure in Acupressure, Pain and Hemodynamic Instability, sponsored by Mersin University. Completed at 1 site in Turkey. Open to participants aged 18 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-01-18.
Sponsored by Mersin University · Not applicable, Interventional, and Supportive care
This randomized controlled study evaluates the effect of acupressure application on the pain level patients after angioography. The hypothesis of this study is that acupressure reduces pain levels and stabilizes hemodynamic variables.
In the study, 124 patients will randomly assigned to acupressure/experimental group and control group. To the acupressure/experimental group (n = 62), an average of 15 minutes will be applied to the LI4 (liver, between thumb and forefinger), P6 (pericardium, three fingers above the wrist) and LI 11 is located the area where the elbow bend. On the other hand, no other intervention will be applied to the control group other than routine treatment and nursing care. The primary outcome of the research is the effect of acupressure on the pain of patients. The secondary outcome of the study is to determine the effect of acupressure on the hemodynamic variables. The pain and hemodynamic variables will be collected before, immediately after the application, 10th, 20th and 30th minutes after the application. Data will also be collected from the control group at the same time.
1,019 studies on the registry are indexed under Peripheral Vascular Diseases; 124 are open to participants now.
This study's enrollment of 124 is above the median of 70 across 721 interventional studies indexed under Peripheral Vascular Diseases.
Browse Peripheral Vascular Diseases studies →Mersin University is the lead sponsor of 173 studies on the registry; 48 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
The experimental group will be given acupressure.
Other: Acupressure
It will only take routine treatment and care.
The experimental group will start with LI4 points and continue P6 and LI11 points. The application will be carried out by determining the priority order of the points with the draw. Attention will be paid to the intensity and duration of the pressure deemed appropriate. Since the individuals' responses will differ, the stiffness and pressure will be adjusted according to the individual's sensitivity not to cause tissue damage. Before starting the application, around the area to be pressed for 20-30 seconds will be gently rubbed with palm. With the gentle rubbing of the surrounding tissue, the tension and tissue sensitivity in warming, relaxing and preparatory will be reduced, and the tissue will be relieved. After, the point determined will be pressed manually for 2 minutes.
Also known as: Acupress
Pain evaluated using the visual analog scale
The total scale score is in the range of 0 cm (minimum) -10 cm (maximum). A score of 0 indicates no pain and a score of 10 indicates very severe pain.
Time frame: Change from before implementation and immediately after, 10th, 20th and 30th minutes after implementation
Systolic blood pressure
Systolic blood pressure (SBP), mmHg
Time frame: Change from before implementation and immediately after, 10th, 20th and 30th minutes after implementation
Diastolic blood pressure
Diastolic blood pressure (DBP), mmHg
Time frame: Change from before implementation and immediately after, 10th, 20th and 30th minutes after implementation
Heart rate
Beats per minute
Time frame: Change from before implementation and immediately after, 10th, 20th and 30th minutes after implementation
Respiratory rate
Lung breathing
Time frame: Change from before implementation and immediately after, 10th, 20th and 30th minutes after implementation
Peripheral oxygen saturation
%, percentage of oxygenated hemoglobin in peripheral arterial blood
Time frame: Change from before implementation and immediately after, 10th, 20th and 30th minutes after implementation
Plan to share: No
This study is completed, as verified in Jan 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Mersin University